- Home
- EHC vs PEN Comparison
EHC vs PEN Comparison
Compare EHC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- PEN
- Stock Information
- Founded
- EHC 1983
- PEN 2004
- Country
- EHC United States
- PEN United States
- Employees
- EHC N/A
- PEN N/A
- Industry
- EHC Hospital/Nursing Management
- PEN Medical/Dental Instruments
- Sector
- EHC Health Care
- PEN Health Care
- Exchange
- EHC Nasdaq
- PEN Nasdaq
- Market Cap
- EHC 9.7B
- PEN 11.1B
- IPO Year
- EHC 1986
- PEN 2015
- Fundamental
- Price
- EHC $101.25
- PEN $267.21
- Analyst Decision
- EHC Strong Buy
- PEN Strong Buy
- Analyst Count
- EHC 8
- PEN 16
- Target Price
- EHC $107.38
- PEN $291.60
- AVG Volume (30 Days)
- EHC 704.3K
- PEN 412.9K
- Earning Date
- EHC 04-23-2025
- PEN 05-06-2025
- Dividend Yield
- EHC 0.67%
- PEN N/A
- EPS Growth
- EHC 28.32
- PEN N/A
- EPS
- EHC 4.46
- PEN 0.36
- Revenue
- EHC $5,373,200,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- EHC $10.10
- PEN $14.26
- Revenue Next Year
- EHC $8.67
- PEN $14.29
- P/E Ratio
- EHC $22.71
- PEN $742.64
- Revenue Growth
- EHC 11.91
- PEN 12.86
- 52 Week Low
- EHC $78.53
- PEN $148.00
- 52 Week High
- EHC $104.55
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- EHC 57.57
- PEN 43.99
- Support Level
- EHC $99.82
- PEN $273.00
- Resistance Level
- EHC $101.96
- PEN $288.57
- Average True Range (ATR)
- EHC 2.18
- PEN 8.17
- MACD
- EHC 0.39
- PEN -1.26
- Stochastic Oscillator
- EHC 92.47
- PEN 33.31
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.